Skip to content
Announcement:

Webinar: hear from our 3 panelists discussing regulatory, technology, and scientific perspectives to accelerate your compound through the clinical development pipeline with predictive retina models

Development of highly-differentiated human primary proximal tubule MPS model (aProximate MPS™ Flow)

Published

29th June, 2023

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

View this resource

The proximal tubule (PT) is the key nephron segment mediating renal drug elimination and is the primary site of drug induced nephrotoxicity However, current animal studies have proved poorly predictive of human outcome. To address this, there has been a recent upsurge in physiological relevant microphysiological systems (MPS) of PT to recapitulate differentiation and function in vitro. Here we present results from our recently developed aProximate MPSTM human PT platform (Patent No:G001336.GB), in which primary PT cells are subject to fluidic media flow and a shear stress between 0.1-2 dynes/cm2.

Download Now

Get our latest updates straight to your inbox